September 5, 2025AAP Grand Rounds

Albuterol-Budesonide Superior to Albuterol Alone for Mild Asthma

View Full Paper

Ask AI

Bookmark

Discussion

Member takes

Implication

Randomized clinical trial reveals reduced severe exacerbations in asthma patients using albuterol-budesonide, indicating significant benefits over albuterol alone.

Key Points

Albuterol-budesonide reduced severe asthma exacerbations compared to albuterol alone, showing superior efficacy.
In the on-treatment population, severe exacerbation rates were 5.1% for albuterol-budesonide versus 9.1% for albuterol, with a hazard ratio of 0.53.
Conducted as a double-blind randomized clinical trial, participants received either albuterol-budesonide or albuterol alone for 12 to 52 weeks.
This study highlights the potential for albuterol-budesonide to significantly improve asthma management in individuals with uncontrolled mild asthma.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/68c23966b210217d6477c160 https://doi.org/10.1542/gr.54-3-27

View Full Paper

Ask AI

Bookmark

Implication

Randomized clinical trial reveals reduced severe exacerbations in asthma patients using albuterol-budesonide, indicating significant benefits over albuterol alone.

Albuterol-Budesonide Superior to Albuterol Alone for Mild Asthma

Discussion

Member takes

Implication

Key Points

Cite This Study

Albuterol-Budesonide Superior to Albuterol Alone for Mild Asthma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider